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Biosynthesis of the hybrid polyketide-nonribosomal peptide antibiotic streptolydigin, 3-methylaspartate, is
utilized as precursor of the tetramic acid moiety. The three genes from the Streptomyces lydicus streptolydigin
gene cluster slgE1-slgE2-slgE3 are involved in 3-methylaspartate supply. SlgE3, a ferredoxin-dependent gluta-
mate synthase, is responsible for the biosynthesis of glutamate from glutamine and 2-oxoglutarate. In addition
to slgE3, housekeeping NADPH- and ferredoxin-dependent glutamate synthase genes have been identified in S.
lydicus. The expression of slgE3 is increased up to 9-fold at the onset of streptolydigin biosynthesis and later
decreases to 2-fold over the basal level. In contrast, the expression of housekeeping glutamate synthases
decreases when streptolydigin begins to be synthesized. SlgE1 and SlgE2 are the two subunits of a glutamate
mutase that would convert glutamate into 3-methylaspartate. Deletion of slgE1-slgE2 led to the production of
two compounds containing a lateral side chain derived from glutamate instead of 3-methylaspartate. Expres-
sion of this glutamate mutase also reaches a peak increase of up to 5.5-fold coinciding with the onset of
antibiotic production. Overexpression of either slgE3 or slgE1-slgE2 in S. lydicus led to an increase in the yield
of streptolydigin.
The vast majority of antibiotic and antitumor drugs belong
either to the polyketide or the nonribosomal families of natural
products. A related family comprises hybrid compounds con-
taining polyketide and nonribosomal peptide moieties. Their
biosynthesis involves the participation of a modular polyketide
synthase (PKS) for the condensation of acyl coenzyme A (acyl-
CoA) precursors and a nonribosomal peptide synthetase
(NRPS) that condenses amino acids after their activation to an
aminoacyl-AMP precursor. Both type I PKSs and NRPSs are
multifunctional enzymes that are organized into modules and
use a similar strategy for the assembly of these short carboxylic
and amino acid building blocks. The minimal set of domains in
a type I PKS includes ketosynthase (KS), acyltransferase, and
acyl-carrier protein activities responsible for the catalysis of
one cycle of polyketide chain elongation. These PKS modules
can contain further domains such as ketoreductase (KR), de-
hydratase (DH), or enoylreductase to reduce the keto groups
generated during the condensation process (9). In a similar
way, a typical minimal NRPS module consists of condensation,
adenylation, and peptidyl carrier protein (PCP) domains (9).
Streptolydigin (compound 1) (Fig. 1) is an inhibitor of bac-
terial RNA polymerase -subunit produced by Streptomyces
lydicus (27, 29) and a potent inhibitor of eukaryotic DNA
polymerase terminal deoxynucleotidyltransferase (6, 7). The
streptolydigin biosynthetic gene cluster has been isolated and
characterized from the producer organism (21). Streptolydigin
belongs to the hybrid polyketide-nonribosomal peptide family
of natural products. The streptolydigin type I PKS, composed
of one loading domain and seven extension modules distrib-
uted over three polypeptides, would condense four units of
malonyl-CoA and four units of methyl-malonyl-CoA and is
proposed to generate the polyketide core. The formation of
the tetramic acid moiety of the molecule involves the partici-
pation of an NRPS system composed of at least two polypep-
tides. Early biosynthetic studies using labeled precursors have
shown the incorporation of propionate, acetate, methionine,
and glutamic acid (suggested to be in form of -methylaspar-
tate) into the main structure of streptolydigin (3, 4, 22, 23). In
addition, recent work in our laboratory has demonstrated the
involvement of SlgZ, an asparaginyl-tRNA synthetase-like en-
zyme, in the 3-methylaspartate tailoring process by amidation
of a 3-methylaspartatyl-NRPS bound to generate 3-methyl-
asparaginyl-NRPS (11). This activity might be followed by the
methylation of NRPS-bound 3-methylasparagine by SlgM to
obtain N-methyl-3-methylasparaginyl-NRPS that then would
be condensed with the polyketide chain synthesized by the
streptolydigin PKS (11) (Fig. 1). Three other genes in the
cluster are predicted to encode two subunits of a glutamate
mutase (GM) (slgE1 and slgE2) and a ferredoxin-dependent
glutamate synthase (GS) (slgE3). We report here the charac-
terization of these three genes and their role in supplying
3-methylaspartate as the precursor for streptolydigin biosyn-
thesis. We have also identified two housekeeping GSs, depen-
dent, respectively, on NADPH and ferredoxin. Deletion of the
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GM genes slgE1 and slgE2 led to the production of a novel
streptolydigin derivative.
MATERIALS AND METHODS
Strains and culture conditions. The bacterial strains used in the present study
were S. lydicus NRRL2433, a streptolydigin producer; Escherichia coli DH10B
(Invitrogen); and ET12567(pUB307) (12). The growth medium for S. lydicus and
mutants was tryptone soy broth. For sporulation, MA medium was used and R5A
was the streptolydigin production medium (8). Growth of S. lydicus in R5A liquid
medium was monitored by measuring absorbance at 600 nm using the diphenyl-
amine assay method for determining DNA content (2, 16). Culture conditions
were those previously described (21). Intergeneric conjugation of Strepto-
myces-E. coli was performed according to standard procedures (12). The E. coli
media were as described previously (25). When plasmid-containing clones were
grown, the medium was supplemented with the appropriate antibiotics: 100 g of
ampicillin/ml, 20 g of tobramycin/ml, 25 g of apramycin/ml, 50 g of thio-
strepton/ml, 50 g of hygromycin/ml, 10 g of tetracycline/ml, 25 g of chlor-
amphenicol/ml, or 50 g of nalidixic acid/ml.
DNA manipulation and plasmids. DNA manipulations were performed ac-
cording to standard procedures for E. coli (25) and Streptomyces (12). Platinum
Pfx DNA polymerase (Invitrogen) and 2.5% dimethyl sulfoxide (DMSO) were
used for all PCR amplifications. The PCR conditions used were as follows: 97°C
for 5 min, followed by 30 cycles of 95°C for 30 s, 55°C for 45 s, and 68°C for 1 min,
with a final extension cycle at 68°C for 10 min. All of the PCR products were
cloned into pCR-BLUNT (Invitrogen) and then sequenced. Other plasmids used
in the present study included pSL1180 (Amersham Pharmacia) for routine clon-
ing, pEFBAoriT (11) for gene replacement, and pEM4T (17) for gene expres-
sion. pLHyg (20) was the source of the hygromycin resistance gene hyg.
Construction of plasmids for gene replacement and complementation of mu-
tants. For deletion of slgE3 two DNA fragments of 1.0 and 1.1 kb, respectively,
were amplified by PCR from cosmid Slg4A8 (21) using oligoprimers HEI9/
HEI10 (PCR A) and HEI11/HEI12 (PCR B) (Table 1). The PCR A fragment
(Fig. 2A) containing 34 bp from the slgE3 5 end was cloned as a SpeI-NsiI
fragment into SpeI-NsiI-digested pEFBAoriT. The resultant plasmid was di-
gested with BamHI-EcoRVI, and the PCR B fragment (Fig. 2A), containing 22
bp from the slgE3 3 end and digested with the same restriction enzymes, was
cloned, yielding plasmid pslgE3. In this construct 1,267 bp of the slgE3 coding
region have been substituted by the apramycin resistance gene aac3(IV). Dele-
tion of genes slgE1 and slgE2 was accomplished by amplification of two DNA
fragments (1.0 and 1.1 kb, respectively) from cosmid Slg4A8 by using the oligo-
primers HEI15/HEI16 (PCR C) and HEI17/HEI18 (PCR D) (Table 1). The
PCR C fragment (Fig. 2D), containing 18 bp from the slgE2 3 end, was cloned
as a SpeI-NsiI fragment into SpeI-NsiI-digested pEFBAoriT. The resultant plas-
mid was digested with BamHI-EcoRVI, and the PCR D fragment (Fig. 2D),
containing 45 bp from the slgE1 5 end and digested with the same restriction
enzymes, was cloned, yielding plasmid pslgE1E2. In this construct, 1,744 bp of
the slgE1-slgE2 coding region were substituted by the apramycin resistance gene
aac3(IV). Finally, pslgE3 and pslgE1E2 were digested with XbaI, and the
gene hyg from pLHyg was subcloned as a SpeI-NheI fragment to obtain plasmids
FIG. 1. Proposed pathway for the biosynthesis of streptolydigin (compound 1). The incorporation of glutamate, in the form of 3-methyl-
aspartate, to generate the tetramic acid lateral side chain is shown in thick lines. M7, PKS module 7; KS, ketosynthase; ATa, acyl transferase
specific for malonyl-CoA; ACP, acyl carrier protein; KR*, inactive ketoreductase; C, condensation domain; A’, SlgN1 adenylation domain; A,
SlgN2 adenylation domain; PCP, peptidyl carrier protein.
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pslgE3Hyg and pslgE1E2Hyg used for the generation of S. lydicus strains
SLME3 and SLME1E2, respectively.
Plasmids pEM4TslgE3 and pEM4TslgE1E2 were constructed for complemen-
tation of S. lydicus strains SLME3 and SLME1E2, respectively. The slgE3 gene
was amplified by PCR from cosmid Slg4A8 by using the oligoprimers HEI13 and
HEI14. The resultant 1.3-kp product was cloned as a BamHI-EcoRI fragment
into BamHI-EcoRI-digested pEM4T, yielding plasmid pEM4TslgE3. The slgE1-
slgE2 genes were amplified by PCR from cosmid Slg4A8 by using the oligoprim-
ers CCL22B and CCL21MF. The resultant 1.8-kp product was cloned as a
BamHI-MfeI fragment into BamHI-EcoRI-digested pEM4T, yielding plasmid
pEM4TslgE1E2. In both constructs, the genes slgE3 and slgE1-slgE2 are under
the control of the ermE* promoter.
Generation of S. lydicus mutant strains. Constructs pslgE3Hyg and
pslgE1E2Hyg were introduced into S. lydicus by intergeneric conjugation from
E. coli ET12567(pUB307). For the generation of the S. lydicus strains SLME3
and SLME1E2, a single-crossover strain, which was apramycin and hygromycin
resistant, was cultured in the absence of selection and then screened for the loss
of hygromycin resistance and the retention of apramycin resistance because of a
double recombination event. The deletion of slgE3 in SLME3 and slgE1-slgE2 in
SLME1E2 were verified by Southern hybridization and PCR amplification by
using the oligoprimers HEI9/HEI12 or HEI15/HEI18, respectively. Plasmids
pEM4T, pEM4TslgE3, and pEM4TslgE1E2 were introduced into S. lydicus wild-
type strain or mutants SLME3 and SLME1E2 by intergeneric conjugation and
transconjugants were selected for resistance to thiostrepton.
UPLC, LC-MS, and NMR spectroscopy methods. Streptolydigin production in
S. lydicus wild-type or mutant strains grown on R5A medium was analyzed by
ultrahigh-performance liquid chromatography (UPLC) and liquid chromatogra-
phy-mass spectrometry (LC-MS) using previously described procedures (21). For
structural elucidation streptolydigin C was purified and characterized by 1H and
13C nuclear magnetic resonance (NMR) experiments. The information regarding
structural characterization of streptolydigin C is given in Table S1 in the sup-
plemental material.
Bioactivity testing. The antibiotic activity of streptolydigin C (compound 3,
Fig. 3A) was assayed via antibiotic disc diffusion assay against Streptomyces albus.
Streptolydigin was used as reference compound. In both cases, 2 g of each
compound was utilized according to a previously described procedure (21).
Identification of S. lydicus housekeeping glutamate synthases. PCR amplifi-
cation of glutamate synthase-encoding regions was performed using degen-
erate oligoprimers (Table 1) and total DNA from S. lydicus NRRL2433. The
oligoprimers HEI-I and HEI-J were designed to locate the presence of an
internal region of an NADPH-dependent glutamate synthase  subunit gene
(gluS-). They were derived from conserved amino acid sequences present in
enzyme SAV6189 from S. avermitilis MA-4680, enzyme SCO2026 from S.
coelicolor A3(2), and enzymes SACE3998 and SACE5742 from Saccharopoly-
TABLE 1. Primers used in this study
Primer Sequence (5–3)a Description
HEI9 AACTAGTCCCCGTCAGCACCCCACG SpeI
HEI10 AAAATGCATACCCCGGGGCAGACAGCC NsiI
HEI11 AAGGATCCGACGACGAGGGAGCCCTC BamHI
HEI12 AAGATATCTGAAGCCCATGCTCTCGG EcoRV
HEI15 AACTAGTTGTGGTCGCCGAGGACGA SpeI
HEI16 AAAATGCATGGCGGTCGAAGACCGATG NsiI
HEI17 AAGGATCCGCTGTGCCGTGCGTCGTC BamHI
HEI18 AAGATATCTGCAGACCGACCGCGGTC EcoRV
HEI13 AAGGATCCGAAGATCCCCGGCGTGGT BamHI
HEI14 AGAATTCGAACGGATTGCTCACGAG EcoRI
CCL22B AAGGATCCGATGGGCAAGGCAATGGA BamHI
CCL21MF AACAATTGCAGCACGAGTGCTCTCAT MfeI
HEI-I GTCGCCTCCGGCCGCTTC Forward for gltS-
HEI-J SCCGACCGGGCAGGTGTC Reverse for gltS-
HEI-F TTCTGCGTCCGCAACTCC Forward for gltS- and -
HEI-C CAGTCSGCRCCSGTGTCR Reverse for gltS- and -
HEI-FR1 CCSTACGACATGGCSYTGCT Forward for gltS-FD
HEI-FR2 CTTGCACACSGCGAGGAACT Reverse for gltS-FD
NDGA AGCGAGTACCTCGTCAACTCCGA Forward for gltS-b
NDGB CATCATGACGCAGCCGGAGA Reverse for gltS-
NDPA AGCGCGAGATCGCCAAGACC Forward for gltS-
NDPB CGCTTGCGCAGCTTCTTGGC Reverse for gltS-
FDA GACATGGCCCTGCTGAACGTCTC Forward for gltS-FD
FDB GGAGCCGACGCAGAGCTTGAAC Reverse for gltS-FD
FDSLGE3A TGGTGCCGCCGGTGTTCAT Forward for slgE3
FDSLGE3B GGATCTCCTCGGTGACGGTGC Reverse for sglE3
CRIS3 ATCGCGCTCAACGGCTAC Forward for sglE2
CRIS4 TAGGGGATGTCCGACGAC Reverse for sglE2
RTNADG1 ACCACGACATCTACTCCATCGAG Forward for gltS-c
RTNADG2 CAGCTTCACGTGGATGCG Reverse for gltS-
RTNADP1 TCAAGATGGAGAAGCGCCA Forward for gltS-
RTNADP2 CGTACGGAACTTGGTGCCC Reverse for gltS-
RTGS1 TCCGAGTTCGCCGACAA Forward for gltS-FD
RTGS2 GGTTTCAGGGAGACGCACTTGAT Reverse for gltS-FD
RTGSSLG1 CCAGCAGATCCGCTTCAT Forward for slgE3
RTGSSLG2 AAGAGCTTCACCCACACCC Reverse for sglE3
RTGMA GATTCACCACCTCGAAACCGT Forward for sglE2
RTGMB TGATCGTCAGCAGTCTCGCTT Reverse for sglE2
HRDBqRT1 CAACCCAGTGGAAGAACGTT Forward for hrdB
HRDBqRT2 TGCGGCACTGACCATCAG Reverse for hrdB
a Restriction sites are underlined in the primer sequences.
b This primer and the following one were used for RT-PCR studies.
c This primer and the following one were used for qRT-PCR studies.
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spora erythraea NRRL2338 (see Fig. 5B). Oligoprimers HEI-F and HEI-C
were designed to locate the presence of the 5 end of an NADPH-dependent
glutamate synthase  subunit (gluS-) and the 3 end of an NADPH-depen-
dent glutamate synthase  subunit (gluS-) genes. Their sequences were
designed from previously mentioned enzymes (see Fig. 5B) and from
NADPH-dependent glutamate synthase  subunits SAV6190 and SAV6258
from S. avermitilis MA-4680, SCO1977, and SCO2025 from S. coelicolor
A3(2) and SACE3997 and SACE5741 from Saccharopolyspora erythraea
NRRL2338 (see Fig. 5C). Oligoprimers HEI-FR1 and HEI-FR2 were de-
signed to locate the presence of an internal region of a housekeeping ferre-
doxin-dependent glutamate synthase gene (gluS-FD). These primers were
designed using the enzymes SAV954 and SAV1232 from S. avermitilis MA-
4680, SSEG09946 from S. sviceus ATCC 29083, and SSAG01435 from Strep-
tomyces sp. strain Mg1 (see Fig. 5D). DNA sequencing of PCR product
obtained was performed on double-stranded DNA templates with the dide-
oxynucleotide chain termination method (26) and the Cy5 Autocycle se-
quencing kit (GE Healthcare). An Alf-express automatic DNA sequencer
(GE Healthcare) was used. Computer-aided database searching and se-
quence analysis were carried out with the University of Wisconsin Genetics
Computer Group software (5) and the BLAST program (1).
Isolation of total RNA. Mycelium corresponding to cultures from S. lydicus
NRRL2433 was obtained at 12, 24, 48, and 72 h during growth in R5A liquid
medium. Mycelium corresponding to cultures from S. lydicus SLME3 and
SLME1E2 was obtained at 72 h during growth in R5A liquid medium. Samples
(15 ml) of each culture were mixed with 2 volumes of RNAprotect bacteria
reagent (Qiagen) and, after vortexing, mycelia were harvested by centrifugation
and immediately frozen at 70°C according to the manufacturer’s instructions.
The total RNA was extracted from frozen mycelium using the lysis method from
the Kirby procedure (12) and purified with a RNeasy Midi kit (Qiagen) accord-
ing to the manufacturer’s instructions. RNA preparations were subjected to
FIG. 2. (A) Scheme representing the replacement in the chromosome of the wild-type slgE3 gene by a version mutated through the insertion
of an apramycin resistance cassette. (B) UPLC analysis of mutant SLME3. (C) UPLC analysis of mutant SLME3 complemented by pEM4TslgE3.
(D) Scheme representing the replacement of the wild-type slgE1-E2 genes by one mutated through the insertion of an apramycin resistance
cassette. (E) UPLC analysis of mutant SLME1E2 and MS analysis of compounds 2 and 3. (F) UPLC analysis of mutant SLME1E2 complemented
by pEM4TslgE1E2. aac(3)IV, apramycin resistance gene; hyg, hygromycin resistance gene; bla, -lactamase gene; 1, streptolydigin; 2, streptolydigin
B; 3, streptolydigin C; AU, arbitrary units.
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additional DNase I treatments (RNase-Free; Qiagen) to eliminate possible chro-
mosomal DNA contamination. The RNA concentration was determined by mea-
suring the absorbance at 260 nm.
Gene expression analysis by reverse transcriptase PCR (RT-PCR). Transcript
detection analysis was carried out by using the SuperScript One-Step RT-PCR
with Platinum Taq DNA polymerase (Invitrogen) with 100 ng of total RNA as a
template. DMSO (5% [vol/vol], final) was added to all reactions, along with
RNAguard RNase inhibitor (Amersham Biosciences; 32.2 U per reaction). The
conditions were as follows: first-strand cDNA synthesis at 50°C for 30 min,
followed by 94°C for 2 min, and then 30 amplification cycles of 95°C for 1 min,
61°C for 1 min, and 68°C for 2 min. Primers (18- to 23-mers; melting temperature
[Tm], 65°C) (Table 1) were designed with the aid of the software Primer Express
v.2.0 (Applied Biosystems) to generate PCR products of 600 bp. The exception
was the slgE2-specific primers CRIS3/CRIS4, which were designed to give a
product of 840 bp. Negative controls for each pair of primers were carried out
with Platinum Taq DNA polymerase (Invitrogen) in the absence of reverse
transcriptase to confirm that amplified products were not due to the presence of
contaminating chromosomal DNA in RNA preparations. The oligonucleotide
primers HRDB-GB1-F and HRDB-GB2-R for hrdB, encoding the constitutively
expressed housekeeping sigma factor, were used as an internal control to assess
the quality of RNA (24). The amount of RNA used for hrdB detection was 300
ng. The RT-PCR analysis was carried out at least three times for each pair of
primers, and the RT-PCR products were separated in agarose gels and visualized
by ethidium bromide staining. The identity of the PCR products was verified by
direct sequencing with one of the amplification primers.
Gene expression analysis by qRT-PCR. Transcript detection analysis by quan-
titative RT-PCR (qRT-PCR) was performed with 0.2 g of RNA. cDNA was
generated with the iScript cDNA synthesis kit (Bio-Rad). PCR amplification was
performed in a 7500 Fast Real-Time PCR System (Applied Biosystems, War-
rington, United Kingdom). The data were analyzed with the software provided
by the supplier. Amplification was carried out in 25 l containing 0.5 g of
cDNA, 1 Power SYBR green (Applied Biosystems), and each primer (Table 1)
at a concentration of 0.4 M. After incubation at 95°C for 10 min, amplification
proceeded with 40 cycles of 95°C for 15 s and 60°C for 1 min. The efficiencies of
the primer sets were measured using a dilution series of cDNA. The raw thresh-
old cycle (CT) values were converted to relative expression levels by the 2CT
method (15) to quantify the relative gene expression. Based on the sequence of
hrdB amplified using primers HRDB-GB1-F and HRDB-GB2-R, two new oligo-
nucleotides (HRDBqRT1 and HRDBqRT2) were designed and used for ampli-
fication of the hrdB transcript as an internal control to quantify the relative
expression of target genes.
RESULTS
Insertional inactivation of glutamate synthase slgE3. SlgE3
shows high similarity to ferredoxin-dependent GSs and to al-
pha subunits of NADPH-dependent GSs from different micro-
organisms with the highest similarity scores being shown by the
FIG. 3. (A) Structures of streptolydigin B (compound 2) and novel derivative streptolydigin C (compound 3) showing the proposed origin of
tetramic acid lateral side chain from glutamate (thick lines). C, condensation domain; A, SlgN1 adenylation domain; A, SlgN2 adenylation
domain; PCP, peptidyl carrier protein. (B) Antibiotic activity of streptolydigin (area 1) and streptolydigin C (area 3) against S. albus. Each paper
disk was soaked with 2 g of the corresponding compound. Control without antibiotic (area C).
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GSs from the archaean bacteria Caldivirga maquilingensis IC-
167 (ZP_01710164), Thermofilum pendens Hrk 5 (YP_920540),
and Methanothermobacter thermautotrophicus strain Delta H
(NP_275248). The involvement of SlgE3 in streptolydigin bio-
synthesis was demonstrated by deleting slgE3 from S. lydicus
(Fig. 2A). Analysis of the products accumulated by mutant
SLM3 (Fig. 2B) showed the production of very small amounts
of streptolydigin with a UPLC retention time of 6.48 min.
Analysis of this peak by MS showed two ions with masses of
601 and 487 m/z [M	H]	 corresponding to the unfragmented
compound and the aglycone fragment, respectively. The mu-
tant SLM3 produced only 2 to 5% of the level of streptolydigin
produced by the wild type. Production of streptolydigin in
mutant SLME3 was fully restored by the introduction of
pEM4TslgE3 containing slgE3 under the control of the ermE*
promoter (Fig. 2C). These experiments indicate that the active
participation of SlgE3 is essential for the usual production
yields of streptolydigin in the wild-type strain. In addition, the
results also suggest that a second GS can partially sustain the
supply of glutamate for the biosynthesis of the antibiotic.
Insertional inactivation of glutamate mutase slgE1 and
slgE2. SlgE1 and SlgE2 show significant similarities to VinH
and VinI, respectively, S and E subunits of coenzyme B12
(adenosylcobalamin)-dependent mutase from S. halstedii (19).
They are also similar to the pairs NikU-NikV, SanU-SanV, and
GlmA-GlmB, S and E subunits of GMs from S. tendae, S.
ansochromogenes, and Actinoplanes friuliensis involved in the
biosynthesis of nikkomycin (13, 14) and friulimycin (10), re-
spectively. The participation of slgE1 and slgE2 in streptolydi-
gin biosynthesis was assessed by the simultaneous deletion of
both genes from S. lydicus, thus generating mutant SLME1E2
(Fig. 2D). Analysis of the products accumulated by this mutant
showed the production of two compounds (compounds 2 and
3) with UV spectra characteristic of streptolydigin (Fig. 2E).
Compound 2 showed a UPLC retention time of 6.10 min and
masses of 587 and 473 m/z [M	H]	, ions corresponding to the
unfragmented compound and the aglycone fragment, respec-
tively. This compound was identical to streptolydigin B (Fig.
3A), previously characterized form S. lydicus mutant SLMZ
(11). Compound 3 presented UPLC retention time of 6.50 min
and masses of 601 and 487 m/z [M	H]	. According to these
masses, this compound could correspond to streptolydigin.
However, after purification of compound 3 and coinjection
with authentic samples of streptolydigin in UPLC, these com-
pounds did not comigrate. Structural elucidation of compound
3 was carried out using one-dimensional 1H, two-dimensional
1H COSY, 1H, 13C HSQC-edited, and HMBC NMR experi-
ments (see Table S1 in the supplemental material). This al-
lowed the identification of this compound as a novel strepto-
lydigin derivative carrying a tetramic acid lateral side chain
directly derived from glutamate instead of 3-methyl-aspartate
and decorated by amidation of the carboxyl group and subse-
quent methylation of the amino group. We designated this
compound streptolydigin C (Fig. 3A). The production of strep-
tolydigin by mutant SLME1E2 was restored by the introduc-
tion of pEM4TslgE1E2 containing slgE1 and slgE2 under the
control of the ermE* promoter (Fig. 2F).
Streptolydigin C, when tested for its antibacterial activity
against S. albus, showed a halo of inhibition slightly bigger than
that of streptolydigin (4.0 versus 3.2 cm in diameter) (Fig. 3B)
or streptolydigin LA (3.0 cm in diameter) (21) and showed
considerably more activity than that of streptolydigin B (2.5 cm
in diameter) reported previously (11).
Expression of slgE3 and slgE1-slgE2 in S. lydicus. The effect
of slgE3 and slgE1-slgE2 on the production of streptolydigin
was also assessed by expressing these genes in S. lydicus wild
type by using constructs pEM4TslgE3 and pEM4TslgE1E2. In
both cases the genes were under the control of the ermE*
promoter. Overexpression of slgE3 led to a 2-fold increase in
streptolydigin production compared to the control S. lydicus/
pEM4T (Fig. 4). Overexpression of slgE1-slgE2 led to a 1.6-
fold increase in streptolydigin production compared to S. lydi-
cus/pEM4T (Fig. 4).
Identification of housekeeping glutamate synthases. The re-
duced amount of streptolydigin produced by mutant SLME3
implies the possible participation of another GS, different from
SlgE3, in supplying glutamate for streptolydigin biosynthesis.
To identify additional GS-encoding genes in the chromosome
of S. lydicus, we used the PCR and oligoprimers derived from
consensus amino acid sequences obtained by comparison of
NADPH- and ferredoxin-dependent GS from different actino-
mycetes (Table 1 and Fig. 5). The PCR product obtained using
the oligoprimers HEI-I and HEI-J was a fragment of 620 bp.
Sequencing of this fragment and comparison of its deduced
amino acid sequence with proteins in databases showed that it
would code for an internal region of an NADPH-dependent
GS  subunit (gluS-) (Fig. 5A and B). The highest similarity
score obtained was with a putative NADPH-dependent GS
large subunit from Streptomyces sp. strain C (ZP_05506017)
(99% identity, 100% similarity). The sequence of the 1,316-bp
PCR product obtained using oligoprimers HEI-F and HEI-C
showed 437 bp coding for the C-terminal end of an NADPH-
dependent GS  subunit (gluS-) and 887 bp for the N-termi-
nal end of an NADPH-dependent GS  subunit (gluS-) (Fig.
5A to C). The highest scores were with an NADPH-dependent
GS large subunit from Streptomyces flavogriseus ATCC 33331
(ZP_04995602) (84% identity, 89% similarity) and an NADPH-
dependent GS small subunit from Streptomyces sp. strain
ACTE (ZP_06271158) (80% identity, 85% similarity). A PCR
product of 520 bp was obtained using the oligoprimers HEI-
FR1 and HEI-FR2, which could code for an internal region of
FIG. 4. Effect of slgE3 or slgE1-slgE2 overexpression in S. lydicus
on streptolydigin production. Cultures were performed on R5A solid
medium, and streptolydigin production was determined by high-pres-
sure liquid chromatography analysis. Experiments were run in tripli-
cate. C, S. lycidus/pEM4T; E3, S. lydicus/pEM4TslgE3; E1/E2, S. lydi-
cus/pEM4TslgE1E2.
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a ferredoxin-dependent GS (gluS-FD) (Fig. 5). The best match
was a ferredoxin-dependent GS from Streptomyces sp. strain
AA4 (ZP_05479083) (85% identity, 91% similarity). The nu-
cleotide sequences of the three PCR products have been de-
posited in the EMBL database with accession codes FR819656,
FR819657, and FR819658, respectively. These results suggest
the existence of at least two additional GS in S. lydicus: an
NADPH-dependent GS constituted by two subunits (GluS-
and GluS-) and a ferredoxin-dependent GS formed by a
single polypeptide (GluS-FD).
We also attempted the identification of additional GM en-
coding genes in the chromosome of S. lydicus using a similar
approach. Oligoprimers were designed from consensus amino
acid sequences obtained after comparison of GM from differ-
ent actinomycetes (data not shown). Furthermore, slgE1 and
slgE2 were also used as probes for Southern hybridization.
None of these approaches was successful, indicating that prob-
ably only the GM encoded by slgE1 and slgE2 is present in the
streptolydigin producer organism, which would account for the
results obtained by deleting these genes in S. lydicus (see
above).
Gene expression analysis of glutamate synthases and gluta-
mate mutase. The expression of GS genes slgE3, gluS-,
gluS-, and gluS-FD and GM gene slgE2 was analyzed in S.
lydicus and in mutants SLME3 and SLME1E2 by RT-PCR in
order to determine their temporal expression patterns in con-
FIG. 5. (A) Scheme representing PCR amplification of glutamate synthase gluS-, gluS-, and gluS-FD from the chromosome of S. lydicus
NRRL2433. (B) Sequence alignments of NADPH-dependent glutamate synthase  subunits showing the conserved regions used for designing
degenerated the oligoprimers HEI-I, HEI-J, and HEI-F. GluS-, S. lydicus NRRL2433; SAV6189, S. avermitilis MA-4680; SCO2026, S. coelicolor
A3(2); SACE3998 and SACE5742, Saccharopolyspora erythraea NRRL2338. (C) Sequence alignments of NADPH-dependent glutamate synthase
 subunits showing the conserved regions used for designing degenerated oligoprimer HEI-C. GluS-, S. lydicus NRRL2433; SAV6190 and
SAV6258, S. avermitilis MA-4680; SCO1977 and SCO2025, S. coelicolor A3(2); SACE3997 and SACE5741, Saccharopolyspora erythraea
NRRL2338. (D) Sequence alignments of ferredoxin-dependent glutamate synthase showing the conserved regions used for designing degenerated
oligoprimers HEI-FR1 and HEI-FR2. SlgE3 and GluS-FD, S. lydicus NRRL2433; SAV954 and SAV1232, S. avermitilis MA-4680; SSEG09946; S.
sviceus ATCC 29083; SSAG01435, Streptomyces sp. strain Mg1. aa, amino acids.
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nection with the biosynthesis of streptolydigin. When moni-
tored in R5A liquid medium, biosynthesis of streptolydigin
occurred in a growth-phase-dependent manner and the anti-
biotic was first detected at 24 h when cultures entered the
stationary phase (Fig. 6A). Total RNA was isolated at 12, 24,
48, and 72 h from cultures of the S. lydicus wild-type strain and
at 72 h from cultures of the mutant strains. The expression of
all four GSs was apparently constitutive, including the expres-
sion of slgE3. As expected, the three housekeeping GS genes
were expressed in both streptolydigin-nonproducing mutants
SLME3 and SLME1E2. In addition, expression of slgE3 was
also confirmed in GM mutant SLME1E2, but it was absent
from GS mutant SLME3. Expression of GM slgE2 increased
after streptolydigin biosynthesis. This gene was also expressed
in GS mutant SLME3 (Fig. 6B).
Expression of GSs and GM was quantified by qRT-PCR
using the same RNA samples. The value obtained for the 12 h
sample was fixed arbitrarily at 1 for reference (Fig. 6C). The
expression level of the housekeeping GSs (gluS-, gluS-, and
gluS-FD) decreased to one-fourth, coinciding with the entry
into the stationary phase (24-h sample). However, expression
of the streptolydigin-related GS slgE3 and GM slgE2 consid-
erably increased at that time (24 h) 9- and 5.5-fold, respectively
(Fig. 6C), coinciding with the onset of streptolydigin produc-
tion (Fig. 6A). Afterward, at 48 and 72 h, the expression of
both genes decreased but kept at 72 h a 2-fold expression with
respect to the 12-h sample.
DISCUSSION
Streptolydigin biosynthesis requires the incorporation of a
3-methylasparagine moiety. Several genes from the strep-
tolydigin biosynthesis gene cluster have been proposed to
encode enzymes that participate in 3-methylaspartate bio-
synthesis. SlgE3 has been proposed to be involved in the
specific supply of glutamate derived from 2-oxoglutarate
and glutamine. SlgE1 and SlgE2 have been proposed to
catalyze the conversion of glutamate into 3-methylaspartate.
This amino is thought to be activated and loaded onto the
SlgN2 NRPS PCP domain by catalyzed by the SlgN1 and
SlgN2 adenylation domains acting together. Once gener-
ated, the NRPS-bound substrate would be further processed
by the activity of 3-methylasparagine synthetase SlgZ, fol-
lowed by N methylation by SlgM to generate NRPS-bound
FIG. 6. (A) Growth and streptolydigin production by S. lydicus wild-type strain in R5A medium. Growth was monitored by measuring the
absorbance at 600 nm for determining DNA content by the diphenylamine assay. Streptolydigin production was spectrophotometrically quantified
at 360 nm by peak area integration (). Experiments were run in triplicate. The arrows show time points when total RNA was isolated.
(B) Transcriptional analysis of S. lydicus GSs (slgE3, gluS-, gluS-, and gluS-FD) and GM (slgE2) by RT-PCR. RNA samples were obtained,
during growth in R5A liquid medium, at 12, 24, 48, and 72 h from S. lydicus wild type and at 72 h from S. lydicus SLME3 and SLME1E2.
(C) Quantification of gene expression by qRT-PCR. The hrdB gene was used as an internal control to quantify the relative expression of target
genes. The expression level of each gene at 12 h was taken as the calibrator. Error bars were calculated from three independent determinations
of mRNA abundance in each sample.
VOL. 193, 2011 STREPTOLYDIGIN PRECURSOR SUPPLY 4221
 o
n
 February 9, 2017 by O
VIEDO
 LIBRARY
http://jb.asm.org/
D
ow
nloaded from
 
N-methyl-3-methylasparagine (Fig. 1) (11). N-Methyl-3-
methylasparagine would be condensed with the preformed
streptolydigin polyketide chain, followed by the remaining
biosynthetic steps: release and cyclization of the polyketide-
nonribosomal peptide to generate the tetramic acid moiety,
epoxidation to obtain streptolydiginone (streptolydigin agly-
con), and finally attachment of L-rhodinose to obtain the
final product (Fig. 1) (21).
The participation of streptolydigin GS and GM enzymes
in the biosynthetic process has been confirmed by inactiva-
tion of the corresponding genes and their expression in S.
lydicus wild type. Deletion of slgE3 reduced the production
of streptolydigin to low levels, indicating the importance of
ferredoxin-dependent GS SlgE3 in supporting antibiotic
biosynthesis by supplying glutamic acid. On the other hand,
expression of slgE3 in S. lydicus enhanced antibiotic produc-
tion. Furthermore, the viability of mutant SLME3 is not
compromised by the absence of SlgE3 since three other GS
encoding genes have been identified in S. lydicus. Two of
these genes (gluS- and gluS-) encode the  and  subunits
of an NADPH-dependent GS, while the third (gluS-FD)
encodes a ferredoxin-dependent GS. These housekeeping
GSs, which support primary metabolism, have been shown
to be expressed throughout S. lydicus growth, their expres-
sion decreasing when the strain reaches the stationary
phase. In contrast, the expression of slgE3 sharply increases
coinciding with the onset of streptolydigin biosynthesis.
Deletion of slgE1 and slgE2 abolished streptolydigin produc-
tion leading to the accumulation of two streptolydigin deriva-
tives streptolydigin B and streptolydigin C both containing
glutamate but differing in an N-methyl group present in strep-
tolydigin C and absent in streptolydigin B. The production of
streptolydigin B has been observed before in an SLMZ mutant
affected in ammonia-dependent 3-methylasparagine synthe-
tase slgZ, which implies that the streptolydigin NRPS is flexible
enough to accept glutamate instead of 3-methylaspartate as a
substrate for the biosynthesis of streptolydigin or streptolydigin
B (11). In addition, the production of streptolydigin C, with a
tetramic lateral side chain modified by amidation and methyl-
ation, implies the flexibility of both SlgZ and SlgM for amidat-
ing and methylating glutamyl-NRPS and glutaminyl-NRPS in-
termediates, respectively. A similar effect has been shown by
disruption of a GM gene involved in the biosynthesis of vice-
nistatin. Inactivation of vinI from S. halstedii led to abolition of
vicenistatin production and to the accumulation of desmethyl-
vicenistatins (18). On the other hand, the expression of slgE1
and slgE2 in S. lydicus improved streptolydigin production, a
positive effect that has also been observed in the production of
nikkomycin by S. ansochromogenes after the expression of
sanU and sanV (14). In accordance with its proposed involve-
ment in streptolydigin biosynthesis, an increase in slgE2 ex-
pression was observed coinciding with the production of the
tetramic acid.
Comparison of the antibacterial activity of streptolydigin,
streptolydigin B, and streptolydigin C gives some clues to a
structure-function relationship. Substitution of 3-methylaspar-
tate (as in streptolydigin) by glutamate (as in streptolydigin C)
apparently increases the antibacterial activity. In addition, the
presence of an acetamide moiety (as in streptolydigin C)
clearly improves the biological activity in comparison with a
compound lacking this group (as in streptolydigin B). This
acetamide moiety has been shown to be important for the
interaction of streptolydigin with the RNA polymerase (28).
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